ストックスクリーナーアプリを入手
8.68
3.95%
0.33
アフターアワーズ：
8.68
前日終値:
$8.35
開ける：
$8.35
24時間の取引高:
1.36M
Relative Volume:
0.74
時価総額：
$1.13B
収益：
$727.33M
当期純損益:
$-108.03M
株価収益率:
-10.28
EPS:
-0.844
ネットキャッシュフロー:
$-21.78M
1週間 パフォーマンス:
+5.60%
1か月 パフォーマンス:
+10.15%
6か月 パフォーマンス:
-12.94%
1年 パフォーマンス:
-8.63%
1日の値動き範囲:
$8.31
$8.74
1週間の範囲:
$7.47
$8.74
52週間の値動き範囲:
$4.72
$13.74
Neogenomics Inc Stock (NEO) Company Profile
Compare NEO vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
8.68 | 1.09B | 727.33M | -108.03M | -21.78M | -0.844 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026 - Clinical Lab Products
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Will NeoGenomics Inc outperform the market in YEAR2026 Earnings Impact & Community Shared Stock Ideas - baoquankhu1.vn
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance
Guidance Update: Can NeoGenomics Inc deliver alpha2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 - National Today
Bearish Setup: Will NeoGenomics Inc stock hit new highs in YEAR2026 Historical Comparison & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Buybacks Report: Why is NeoGenomics Inc stock going up2026 Price Swings & Safe Swing Trade Setups - baoquankhu1.vn
Setup Watch: Can NeoGenomics Inc keep up with sector leaders2026 Levels & Daily Entry Point Trade Alerts - baoquankhu1.vn
Tudor Investment Corp ET AL Trims NeoGenomics, Inc. $NEO Stake - National Today
NeoGenomics, Inc. $NEO Stake Trimmed by Tudor Investment Corp ET AL - MarketBeat
Published on: 2026-04-09 16:25:20 - baoquankhu1.vn
NeoGenomics, Inc. (NASDAQ: NEO) Q4 2025 earnings call transcript - MSN
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
NeoGenomics to Report Q1 2026 Earnings on April 28 - National Today
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance UK
NEOGENOMICS INC ($NEO) CEO 2025 Pay Revealed - Quiver Quantitative
NeoGenomics (NASDAQ: NEO) seeks approval to expand 2023 equity incentive plan - Stock Titan
Aberdeen Group plc Buys 1,006,676 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics (NEO) COO nets shares after 17,562-unit RSU vesting - Stock Titan
NeoGenomics (NEO) CEO exercises RSUs and uses shares to cover taxes - Stock Titan
NeoGenomics Inc stock: Precision oncology leader facing growth hurdles - AD HOC NEWS
NeoGenomics, Inc. (NEO) stock price, news, quote and history - Yahoo Finance UK
NeoGenomics Inc Stock: Precision Oncology Leader Faces Growth Challenges in Competitive Diagnostics - AD HOC NEWS
NEO|Neogenomics Inc|Price:7.995|Chg%:-0.00 - TradingKey
Growth Value: Why is NeoGenomics Inc stock going upWeekly Market Outlook & Capital Efficient Trade Techniques - baoquankhu1.vn
Geopolitics Watch: Will NeoGenomics Inc outperform the market in YEAR2026 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (NEO) Movement - Stock Traders Daily
NeoGenomics Inc Stock: A Key Player in Cancer Diagnostics Amid Evolving Healthcare Demands - AD HOC NEWS
Loss Report: Should you buy the dip on NeoGenomics Inc2026 Summary & Consistent Return Investment Signals - baoquankhu1.vn
NeoGenomics Q2 2025 Earnings Preview - MSN
Tudor Investment Corp ET AL Sells 320,361 Shares of NeoGenomics, Inc. - National Today
Tudor Investment Corp ET AL Sells 320,361 Shares of NeoGenomics, Inc. $NEO - MarketBeat
GRI Bio (NASDAQ:GRI) versus NeoGenomics (NASDAQ:NEO) Financial Contrast - Defense World
Vanguard files 13G/A: NeoGenomics (NEO) ownership shows 0 shares - Stock Titan
Dip Buying: Whats the analyst consensus on NeoGenomics Inc2026 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
NeoGenomics invites engagement on innovation in oncology at USCAP event - Traders Union
NeoGenomics slides more than 5% despite fourth-quarter earnings beat - MSN
Aug PreEarnings: Is NeoGenomics Inc stock a falling knife or bargain buyTake Profit & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug Retail: Is NeoGenomics Inc gaining market share2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Aug Chart Watch: Can NeoGenomics Inc deliver alpha2026 Institutional Moves & Smart Allocation Stock Reports - baoquankhu1.vn
NEO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeoGenomics (NEO) launches RaDaR ST to capture share in $20B MRD market - msn.com
Discipline and Rules-Based Execution in NEO Response - Stock Traders Daily
Medicare Coverage for PanTracer LBx Liquid Biopsy Could Be A Game Changer For NeoGenomics (NEO) - simplywall.st
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market - Insider Monkey
11 Most Buzzing Stocks to Buy with the Highest Upside Potential - Insider Monkey
NeoGenomics offers preview of booth presence at USCAP2026 - Traders Union
NeoGenomics Beats Investor Suit Over Growth Driver Claims - Law360
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
1.41%
1.61%
大文字化:
|
ボリューム (24 時間):